The Association between Serum Cytokine and Chemokine Levels and Antiviral Response by Entecavir Treatment in Chronic Hepatitis B Patients
Antiviral Therapy · 2018-04 · 23 (3) · 239-248
DOI: 10.3851/imp3196 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antiviral Therapy, online erschienen am 01.04.2017. Verfasst von Mio Kurihara und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Metabolism, Graduate School of Biomedical & Health Sciences, Applied Life Sciences, Institute of Biomedical & Heal…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Background
Although nucleoside/nucleotide analogue therapy is thought to suppress chronic hepatitis B (CHB) via regulation of inflammatory cytokines/chemokines, the mechanism is still unclear. In this study, serum cytokine/ chemokine levels were measured in CHB patients treated with entecavir, and the association with antiviral response was analysed.
Methods
A total of 78 Japanese patients with CHB were enrolled, and serum cytokine/chemokine levels were measured at baseline and at 12, 24 and 48 weeks of entecavir treatment using the MULTIPLEX kit.
Results
Antiviral response to entecavir treatment was significantly associated with hepatitis B surface antigen (HBsAg) titre and serum interferon-gamma-inducible protein 10 (IP-10) level (12w; P=0.0002; OR=0.020 [95% CI 0.002, 0.156], P=0.003; OR=0.042 [95% CI 0.005, 0.336], respectively). HBe-positive patients whose serum macrophage-derived chemokine (MDC) level was lower (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Metabolism, Graduate School of Biomedical & Health Sciences, Applied Life Sciences, Institute of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan.
- Liver Research Project Center, Hiroshima University, Hiroshima, Japan.
- Natural Science Center for Basic Research and Development, Hiroshima University, Hiroshima, Japan.
- Department of Hepatology, Hiroshima Red Cross Hospital and Atomic Bomb Survivors Hospital, Hiroshima, Japan.
- Department of Clinical Studies, Radiation Effects Research Foundation, Hiroshima, Japan.
- Center for Medical Specialist Graduate Education and Research, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Zitieren
APA
Kurihara, M., Tsuge, M., Murakami, E., Mori, N., Ohishi, W., Uchida, T., Fujino, H., Nakahara, T., Abe-Chayama, H., Kawaoka, T., Miki, D., Hiramatsu, A., Imamura, M., Kawakami, Y., Aikata, H., Ochi, H., Zhang, Y., Makokha, G. N., Hayes, C. N., & Chayama, K. (2018). The Association between Serum Cytokine and Chemokine Levels and Antiviral Response by Entecavir Treatment in Chronic Hepatitis B Patients. Antiviral Therapy, 23(3), 239-248. https://doi.org/10.3851/imp3196
Vancouver
Kurihara M, Tsuge M, Murakami E, Mori N, Ohishi W, Uchida T, et al. The Association between Serum Cytokine and Chemokine Levels and Antiviral Response by Entecavir Treatment in Chronic Hepatitis B Patients. Antiviral Therapy. 2018;23(3):239-248. doi:10.3851/imp3196
BibTeX
@article{Kurihara2018,
author = {Kurihara, Mio and Tsuge, Masataka and Murakami, Eisuke and Mori, Nami and Ohishi, Waka and Uchida, Takuro and Fujino, Hatsue and Nakahara, Takashi and Abe-Chayama, Hiromi and Kawaoka, Tomokazu and Miki, Daiki and Hiramatsu, Akira and Imamura, Michio and Kawakami, Yoshiiku and Aikata, Hiroshi and Ochi, Hidenori and Zhang, Yizhou and Makokha, Grace Naswa and Hayes, C Nelson and Chayama, Kazuaki},
title = {The Association between Serum Cytokine and Chemokine Levels and Antiviral Response by Entecavir Treatment in Chronic Hepatitis B Patients},
journal = {Antiviral Therapy},
year = {2018},
volume = {23},
number = {3},
pages = {239--248},
doi = {10.3851/imp3196}
}
EUVIMED